Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-056835
Filing Date
2006-03-16
Accepted
2006-03-16 17:01:11
Documents
8
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 CYTOGEN CORPORATION FORM 10-K d10k.htm 10-K 1241355
2 SUBSIDIARIES OF THE COMPANY dex21.htm EX-21 2150
3 CONSENT OF KPMG LLP dex231.htm EX-23.1 3087
4 302 CERTIFICATION PRESIDENT AND CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 6375
5 302 CERTIFICATION - SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 6425
6 906 CERTIFICATION - PRESIDENT AND CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 3655
7 906 CERTIFICATION - SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 3720
8 FINANCIAL STATEMENT OF PSMA DEVELOPMENT COMPANY LLC AND NOTES THERETO. dex991.htm EX-99.1 140227
  Complete submission text file 0001193125-06-056835.txt   1408385
Mailing Address 650 COLLEGE RD EAST STE 3100 PRINCETON NJ 08540
Business Address 650 COLLEGE RD EAST STE 3100 PRINCETON NJ 08540 6099878200
CYTOGEN CORP (Filer) CIK: 0000725058 (see all company filings)

EIN.: 222322400 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-14879 | Film No.: 06692737
SIC: 2834 Pharmaceutical Preparations